Digitalizing Communications In An Age Of Remote Learning

In light of the rapid developments regarding the recent coronavirus outbreak, we are seeing its impact across numerous industries worldwide, including pharmaceuticals and biotechnology. It is becoming increasingly apparent that businesses need to adapt to flexible ways of working and new ways of marketing their products.

COVID-19 has led to the cancellation of many conferences, tradeshows and business meetings, meaning alternative approaches are required to connect with Health Care Professionals (HCPs) and other influential target audiences. Now is the time for pharmaceutical companies to completely digitalize their approach to product marketing, facilitating connections without a conference booth or in-person representative.

Marketing campaigns have an increased need to be implemented remotely, highlighting the importance of high-quality digital content. Random42 create such content in the form of animation (MoA/MoD), interactive experiences and other digital solutions to explain the science behind a product, removing the need for direct human interaction.

Digital assets can be leveraged across various remote learning applications:

  • Virtual conferences
  • Virtual medical meetings
  • Presentation assets
  • Remote learning tool kits for HCPs
  • Remote learning tool kits for patient education
  • Training tools for sales
  • Remote product demonstration
  • Interactive apps
  • Websites / Social Media
  • PR and media Kits
  • Other digital marketing collateral
Remote learning Killing Cancer

These ongoing digital changes will facilitate remote learning for our clients,
meaning effective communication without a physical presence

Random42 is the global leader in medical animation and scientific storytelling

Get in touch now to discuss digitalizing your marketing approach to facilitate remote learning across your campaign.



‘‘For experts, there’s limited time in which they will interact with this content, so getting a message across quickly is crucial, and this medium does it very well.
Product Manager, GSK

Bristol-Myers Squibb

‘‘Their turnaround time sets them apart from the rest of the field. The fact they can turnaround lots of comments in a couple of days is impressive, whereas that took weeks with other agencies we worked with. They’re well above the benchmark.
Oncology Clinical Liaison, Bristol-Myers Squibb

‘‘It was a combination equally of quality of work but also the comfort and confidence that I knew I would be working with PhDs. They gave me the confidence that they would have the ability to understand. The other companies didn’t have those sorts of people on staff, they were just good animators. That was the area where I felt that I could trust Random42 would deliver.’’
Senior Product Manager, Spectranetics

Amgen Logo

‘‘I have been to a lot of conferences and I have seen a lot of videos both from competitors and internally – in my eyes it is night and day. The quality Random42 have is not one step ahead, it is far ahead compared to what I have seen before.’’
Product Manager, Amgen

We are a Queen’s award winner for international trade.